Compile Data Set for Download or QSAR
Report error Found 197 Enz. Inhib. hit(s) with all data for entry = 8469
TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250673(US9447148, 9.55 | US9447148, 9.42)
Affinity DataEC50:  0.00200nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250661(US9447148, 9.30)
Affinity DataEC50:  0.00200nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250673(US9447148, 9.55 | US9447148, 9.42)
Affinity DataEC50:  0.00200nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250668(US9447148, 9.50 | US9447148, 9.37)
Affinity DataEC50:  0.00300nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250649(US9447148, 9.18)
Affinity DataEC50:  0.00300nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250668(US9447148, 9.50 | US9447148, 9.37)
Affinity DataEC50:  0.00300nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250653(US9447148, 9.22)
Affinity DataEC50:  0.00400nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250651(US9447148, 9.20)
Affinity DataEC50:  0.00400nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250652(US9447148, 9.21)
Affinity DataEC50:  0.00400nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250648(US9447148, 9.17)
Affinity DataEC50:  0.00400nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250642(US9447148, 9.10)
Affinity DataEC50:  0.00400nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM135768(US8846601, 153 | US9458201, 153 | US10179804, Exam...)
Affinity DataEC50:  0.00500nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250661(US9447148, 9.30)
Affinity DataKi:  0.00500nM ΔG°:  -67.1kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250643(US9447148, 9.11)
Affinity DataEC50:  0.00500nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250671(US9447148, 9.53 | US9447148, 9.40)
Affinity DataEC50:  0.00600nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250634(US9447148, 9.31 | US9447148, 9.2)
Affinity DataEC50:  0.00600nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250660(US9447148, 9.29)
Affinity DataEC50:  0.00600nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250655(US9447148, 9.24)
Affinity DataEC50:  0.00600nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250671(US9447148, 9.53 | US9447148, 9.40)
Affinity DataEC50:  0.00600nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250654(US9447148, 9.23)
Affinity DataEC50:  0.00700nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250633(US9447148, 9.1)
Affinity DataEC50:  0.00700nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250659(US9447148, 9.28)
Affinity DataEC50:  0.00700nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250672(US9447148, 9.54 | US9447148, 9.41)
Affinity DataEC50:  0.00800nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250635(US9447148, 9.3)
Affinity DataEC50:  0.00800nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250672(US9447148, 9.54 | US9447148, 9.41)
Affinity DataEC50:  0.00800nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250641(US9447148, 9.9)
Affinity DataEC50:  0.00800nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250658(US9447148, 9.27)
Affinity DataEC50:  0.00900nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250653(US9447148, 9.22)
Affinity DataKi:  0.0100nM ΔG°:  -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250652(US9447148, 9.21)
Affinity DataKi:  0.0100nM ΔG°:  -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250633(US9447148, 9.1)
Affinity DataKi:  0.0100nM ΔG°:  -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250645(US9447148, 9.13)
Affinity DataEC50:  0.0100nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250642(US9447148, 9.10)
Affinity DataKi:  0.0100nM ΔG°:  -65.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250634(US9447148, 9.31 | US9447148, 9.2)
Affinity DataKi:  0.0120nM ΔG°:  -64.8kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250647(US9447148, 9.15)
Affinity DataEC50:  0.0120nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250638(US9447148, 9.6)
Affinity DataEC50:  0.0140nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250668(US9447148, 9.50 | US9447148, 9.37)
Affinity DataKi:  0.0140nM ΔG°:  -64.4kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250668(US9447148, 9.50 | US9447148, 9.37)
Affinity DataKi:  0.0140nM ΔG°:  -64.4kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250673(US9447148, 9.55 | US9447148, 9.42)
Affinity DataKi:  0.0150nM ΔG°:  -64.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250649(US9447148, 9.18)
Affinity DataKi:  0.0150nM ΔG°:  -64.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250644(US9447148, 9.12)
Affinity DataEC50:  0.0150nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250673(US9447148, 9.55 | US9447148, 9.42)
Affinity DataKi:  0.0150nM ΔG°:  -64.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250658(US9447148, 9.27)
Affinity DataKi:  0.0150nM ΔG°:  -64.3kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250674(US9447148, 9.43)
Affinity DataEC50:  0.0160nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250643(US9447148, 9.11)
Affinity DataKi:  0.0200nM ΔG°:  -63.5kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250639(US9447148, 9.7)
Affinity DataEC50:  0.0250nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250637(US9447148, 9.5)
Affinity DataEC50:  0.0250nMpH: 7.5 T: 2°CAssay Description:Accumulation of intracellular cAMP was examined as a measure of the ability of the peptides of the present invention to elicit a functional response ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250651(US9447148, 9.20)
Affinity DataKi:  0.0250nM ΔG°:  -62.9kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250648(US9447148, 9.17)
Affinity DataKi:  0.0250nM ΔG°:  -62.9kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250660(US9447148, 9.29)
Affinity DataKi:  0.0250nM ΔG°:  -62.9kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetMelanocyte-stimulating hormone receptor(Human)
Palatin Technologies

US Patent
LigandPNGBDBM250655(US9447148, 9.24)
Affinity DataKi:  0.0300nM ΔG°:  -62.5kJ/molepH: 7.5 T: 2°CAssay Description:A competitive inhibition binding assay was performed using membrane homogenates prepared from HEK-293 cells that express recombinant hMCR-1a or hMCR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

Displayed 1 to 50 (of 197 total ) | Next | Last >>
Jump to: